Morihiko Inamine Selected Research

Morihiko Inamine Research Topics

Disease

11	Neoplasms (Cancer) 05/2017 - 02/2003
6	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2014 - 04/2011
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2013 - 01/2008
5	Carcinogenesis 10/2012 - 03/2004
4	Carcinoma (Carcinomatosis) 01/2014 - 11/2005
4	Aberrant Crypt Foci 01/2009 - 03/2004
4	Body Weight (Weight, Body) 01/2009 - 03/2004
2	Uterine Neoplasms (Uterine Cancer) 06/2014 - 10/2011
2	Adenocarcinoma 04/2012 - 11/2005
1	Wolffian tumor 05/2017
1	Esophagitis 06/2014
1	Leukopenia 06/2014
1	Uterine Cervical Dysplasia 10/2012
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 06/2012
1	Edema (Dropsy) 10/2011
1	Enterocolitis 10/2011
1	Papillomavirus Infections 05/2010
1	Premature Birth (Birth, Premature) 10/2008
1	Infections 10/2008
1	Ovarian Cysts (Ovarian Cyst) 09/2008
1	Lymphocele 07/2008
1	Hydronephrosis 07/2008
1	Endometrial Neoplasms (Endometrial Cancer) 07/2008
1	Neoplasm Metastasis (Metastasis) 02/2008
1	Clear Cell Adenocarcinoma 12/2007
1	Hemorrhage 07/2007
1	Adenoma (Adenomas) 11/2005
1	Colonic Neoplasms (Colon Cancer) 11/2005
1	Choriocarcinoma 04/2005

Drug/Important Bio-Agent (IBA)

5	AzoxymethaneIBA 01/2009 - 03/2004
4	beta CateninIBA 07/2006 - 03/2004
3	Biomarkers (Surrogate Marker)IBA 05/2010 - 10/2004
2	Paclitaxel (Taxol)FDA LinkGeneric 05/2017 - 04/2012
2	Cisplatin (Platino)FDA LinkGeneric 04/2012 - 08/2008
2	milk-derived factorIBA 01/2009 - 10/2004
2	MucinsIBA 01/2009 - 10/2004
2	Dimenhydrinate (DMH)FDA LinkGeneric 12/2005 - 10/2004
2	1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA 12/2005 - 10/2004
1	Estrogens (Estrogen)FDA Link 05/2017
1	Imatinib Mesylate (Gleevec)FDA Link 05/2017
1	Mucin-1 (CA 15-3 Antigen)IBA 05/2017
1	Carboplatin (JM8)FDA LinkGeneric 05/2017
1	VimentinIBA 05/2017
1	Progesterone Receptors (Progesterone Receptor)IBA 05/2017
1	Calbindin 2IBA 05/2017
1	Inhibins (Inhibin)IBA 05/2017
1	Keratins (Keratin)IBA 05/2017
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 02/2016
1	TensinsIBA 02/2016
1	EmeticsIBA 06/2014
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2014
1	dimemorfan (AT 17)IBA 01/2014
1	Hemoglobins (Hemoglobin)IBA 10/2013
1	Vascular Endothelial Growth Factor CIBA 10/2012
1	AntibodiesIBA 10/2012
1	SmokeIBA 10/2012
1	NucleotidesIBA 05/2010
1	CarcinogensIBA 01/2009
1	GlycosphingolipidsIBA 01/2009
1	Mitogen-Activated Protein Kinase 3IBA 12/2006
1	AnthraquinonesIBA 12/2006
1	Emodin (Archin)IBA 12/2006
1	Messenger RNA (mRNA)IBA 07/2006
1	Dextran SulfateIBA 07/2006
1	1- O- beta- glucosyl- N- 2'- hydroxyarachidoyl- 4,8- sphingadienineIBA 12/2005
1	indole-3-carbinolIBA 11/2005
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 11/2005
1	DNA (Deoxyribonucleic Acid)IBA 04/2005
1	AntigensIBA 04/2005
1	Alcian BlueIBA 10/2004
1	AntioxidantsIBA 03/2004
1	Chromogranin AIBA 02/2003
1	Phosphopyruvate Hydratase (Enolase)IBA 02/2003

Therapy/Procedure

11	Radiotherapy 05/2014 - 12/2007
8	Chemoradiotherapy 06/2014 - 01/2008
4	Therapeutics 05/2017 - 11/2005
4	Subcutaneous Injections 01/2009 - 03/2004
3	Hysterectomy 05/2017 - 07/2008
2	Brachytherapy 10/2013 - 07/2013
1	Salpingo-oophorectomy 05/2017
1	Combination Drug Therapy (Combination Chemotherapy) 05/2017
1	Trachelectomy 01/2014
1	Drug Therapy (Chemotherapy) 06/2012
1	Lasers (Laser) 10/2008
1	Cystectomy 09/2008
1	Lymph Node Excision (Lymph Node Dissection) 07/2008
1	Decompression 07/2007
1	Chemoprevention 11/2005